Papp, K. A., Merola, J. F., Gottlieb, A. B., Griffiths, C. E., Harris, K. K., Cross, N., Peterson, L., Cioffi, C., & Blauvelt, A. (2019). Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study. SKIN The Journal of Cutaneous Medicine, 3, S35. https://doi.org/10.25251/skin.3.supp.35